CAMP - CAMP4 Therapeutics Corporation Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.5 -0.09 (-2.57%) --- --- --- -0.11 (-3.14%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.0%)

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.62
Diluted EPS:
-0.62
Basic P/E:
-5.5
Diluted P/E:
-5.5
RSI(14) 1m:
0.0
VWAP:
3.41
RVol:
0.6663

Events

Period Kind Movement Occurred At
1m Price increase 1m 3.49 +0.04 (+1.16%) Oct 15 15:55
1m Price decrease 1m 3.47 -0.04 (-1.14%) Oct 15 15:51
1m Price decrease 1m 3.5 -0.05 (-1.41%) Oct 15 15:49
1m Price increase 1m 3.54 +0.04 (+1.14%) Oct 15 15:27
10m Price decrease 10m 3.42 -0.16 (-4.48%) Oct 15 15:23

Related News